This $480,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports research by The Cleveland Clinic Foundation, a non-profit academic medical center, to study the role of the citron kinase protein in castration-resistant prostate cancer. The 2-year project, beginning on May 1, 2024, seeks to gain mechanistic insights that could lead to new therapeutic opportunities for this challenging form of prostate cancer. As a leading research institution, The Cleveland Clinic Foundation has a history of successfully delivering high-impact medical research projects for federal agencies like the Department of Veterans Affairs, Department of Defense, and National Institutes of Health through both prime and subcontract awards.
Generated 12/10/24, 1:05 PM